Britannia Life Sciences

CSE-BLAB
Canadian Securities Exchange
Healthcare Biotechnology
Global Rank
#42053
Country Rank
#1561
Market Cap
8.22 M
Price
0.0616
Change (%)
21.43%
Volume
21,110

Britannia Life Sciences (CSE-BLAB) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
11/18/2021 1:10 x0.1 x0.0004 Reverse
04/14/2016 1:25 x0.04 x0.004 Reverse
01/27/2014 1:10 x0.1 x0.1 Reverse

Frequently Asked Questions

  • How much would Britannia Life Sciences stock be worth if it never split?
    If Britannia Life Sciences (stock symbol: CSE-BLAB) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-10) that occurred on 11/18/2021.
  • Britannia Life Sciences (stock symbol: CSE-BLAB) has undergone a total of three stock splits. The most recent split occurred on 11/18/2021. One share bought prior to the first split on 01/27/2014 would now equal 0.00 shares.
  • Britannia Life Sciences (stock symbol: CSE-BLAB) has undergone three stock splits in its history. The most recent split, a 1-for-10 split, occurred on 11/18/2021. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.